Results
Phase 2
This trial looked at anastrozole for women’s cancers that have come back or spread elsewhere in the body. This is recurrent or advanced cancer.
It was for women:
who had a women’s cancers (gynaecological cancer)
whose cancer responds to changes in hormone levels – this is called hormone receptor positive cancer
after the
Cancer Research UK supported this trial.
The trial was open for women to join between 2012 and 2016. The researchers presented the results at a conference in 2018.
Recruitment start: 1 May 2012
Recruitment end: 30 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard Edmondson
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NHS Greater Glasgow and Clyde
NHR Clinical Research Network: Cancer
University of Glasgow
This is Cancer Research UK trial number CRUK/10/056
Last reviewed: 28 October 2020
CRUK internal database number: 7398
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
